|
Age (per year)
|
0.997
|
0.962-1.033
|
0.861
| | | |
|
Gender (male vs. female)
|
0.892
|
0.268-2.969
|
0.852
| | | |
|
Liver cirrhosis (with vs. without)
|
0.939
|
0.401-2.202
|
0.886
| | | |
|
Child-Pugh class (A vs. B)
|
0.304
|
0.111-0.829
|
0.020
|
0.461
|
0.155-1.366
|
0.162
|
|
Main portal trunk invasion (with vs. without)
|
1.098
|
0.520-2.318
|
0.805
| | | |
|
Node metastasis (with vs. without)
|
0.809
|
0.393-1.664
|
0.565
| | | |
|
Baseline tumor size (per 1 cm)
|
1.045
|
0.958-1.140
|
0.317
| | | |
|
Baseline AFP (per 100 ng/mL)
|
1.000
|
0.997-1.002
|
0.827
| | | |
|
Baseline DCP (per 100 mAU/mL)
|
1.002
|
1.001-1.003
|
0.005
| | | |
|
Radiation dose (per 100 cGy)
|
0.931
|
0.866-1.001
|
0.054
| | | |
|
Objective response after CCRT (with vs. without)
|
0.560
|
0.267-1.174
|
0.125
| | | |
|
AFP after CCRT (per 100 ng/mL)
|
1.000
|
0.998-1.002
|
0.962
| | | |
|
DCP after CCRT (per 100 mAU/mL)
|
1.004
|
1.002-1.006
|
<0.001
|
1.003
|
1.001-1.005
|
0.001
|
|
Additional TACE (with vs. without)
|
0.590
|
0.269-1.299
|
0.190
| | | |
|
Round of HAIC
|
0.914
|
0.831-1.005
|
0.062
| | | |
